YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects
出版年份 2020 全文链接
标题
YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects
作者
关键词
-
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 86, Issue 1, Pages 33-43
出版商
Springer Science and Business Media LLC
发表日期
2020-06-10
DOI
10.1007/s00280-020-04098-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Role for polo-like kinase 4 in mediation of cytokinesis
- (2019) Michael F. Press et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PLK4: a promising target for cancer therapy
- (2019) Yi Zhao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
- (2018) Masanori Kawakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
- (2018) Xiangdong Tian et al. Cell Death & Disease
- High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer
- (2018) Yao He et al. Molecular Medicine Reports
- YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect
- (2018) Qian Lei et al. Cell Death & Disease
- Synthesis and biological evaluation of (E)-4-(3-arylvinyl-1H-indazol-6-yl)pyrimidin-2-amine derivatives as PLK4 inhibitors for the treatment of breast cancer
- (2017) Zhihao Liu et al. RSC Advances
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Plk4 Promotes Cancer Invasion and Metastasis through Arp2/3 Complex Regulation of the Actin Cytoskeleton
- (2016) Karineh Kazazian et al. CANCER RESEARCH
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer
- (2015) Rosemary D. Cress et al. OBSTETRICS AND GYNECOLOGY
- Understanding the Polo Kinase machine
- (2015) V Archambault et al. ONCOGENE
- Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
- (2014) Andrew J. Holland et al. CANCER CELL
- Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
- (2014) Jacqueline M. Mason et al. CANCER CELL
- From Plk1 to Plk5
- (2011) Guillermo de Cárcer et al. CELL CYCLE
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability
- (2010) Andrew J. Holland et al. JOURNAL OF CELL BIOLOGY
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Polo-like kinase 4: the odd one out of the family
- (2010) James E Sillibourne et al. Cell Division
- Centrioles, Centrosomes, and Cilia in Health and Disease
- (2009) Erich A. Nigg et al. CELL
- Erratum: Polo-like kinases: conservation and divergence in their functions and regulation
- (2009) Vincent Archambault et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started